Významné publikace

Publikační okénko obsahuje výběr z impaktovaných publikací fakulty od roku 2006 do současnosti. Chceme tak upozornit akademickou obec na významnější publikace, které vyšly u nás na fakultě, a blíže představit vědecké úspěchy jednotlivých pracovišť. Publikace vybíráme na základě několika kritérií, zejména IF a podílu autorů z 2. LF UK.

Immunoprofiling of Monocytes in STAT1 Gain-Of-Function Chronic Mucocutaneous Candidiasis

14. 3. 2023

Marketa Bloomfield, Irena Zentsova, Tomas Milota, Anna Sediva and Zuzana Parackova. Frontiers in Immunology. 2022 September 12. IF: 8,786. doi

Číst více

Standardization of Workflow and Flow Cytometry Panels for Quantitative Expression Profiling of Surface Antigens on Blood Leukocyte Subsets: An HCDM CDMaps Initiative

14. 3. 2023

Daniela Kužílková, Joan Puñet-Ortiz, Pei M. Aui, Javier Fernández, Karel Fišer, Pablo Enge, Menno C. van Zelm and Tomáš Kalina. Frontiers in Immunology. 2022 February 11. IF: 7,561. doi

Číst více

Distinct CD8 T Cell Populations with Differential Exhaustion Profiles Associate with Secondary Complications in Common Variable Immunodeficiency

9. 3. 2023

Adam Klocperk, David Friedmann, Alexandra Emilia Schlaak, Susanne Unger, Zuzana Parackova, Sigune Goldacker, Anna Sediva, Bertram Bengsch & Klaus Warnatz. Journal of Clinical Immunology. 2022 May 19. IF: 8,542. doi.

Číst více

Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety

21. 2. 2023

Monika Svorcova, Rene Novysedlak, Robert Lischke, Jiri Vachtenheim Jr and Zuzana Strizova. Frontiers in Immunology. 2022 June 1. IF: 8,786. doi.

Číst více

Immunogenicity and Safety of the Booster bnt162b2 Vaccine in Patients With Axial Spondyloarthritis Treated With Biological Disease-Modifying Drugs

21. 2. 2023

Jitka Smetanova, Tomas Milota, Michal Rataj, Jana Hurnakova, Hana Zelena, Anna Sediva and Rudolf Horvath. Frontiers in Immunology. 2022 September 23. IF: 8,786
doi.

Číst více

Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity - Results From a Multicenter Nationwide Study

14. 2. 2023

Tomas Milota, Marta Sobotkova, Jitka Smetanova, Marketa Bloomfield, Jana Vydlakova, Zita Chovancova, Jiri Litzman, Roman Hakl, Jiri Novak, Ivana Malkusova, Jana Hanzlikova, Dalibor Jilek, Beata Hutyrova, Vitezslav Novak, Irena Krcmova, Anna Sediva and Pavlina Kralickova. Frontiers in Immunology. 2022 February 28. IF: 8,786
doi.org/10.3389/fimmu.2022.835770

Číst více

Přepínač jazyka

Přepínač jazyka

Významné publikace

Immunoprofiling of Monocytes in STAT1 Gain-Of-Function Chronic Mucocutaneous Candidiasis

Standardization of Workflow and Flow Cytometry Panels for Quantitative Expression Profiling of Surface Antigens on Blood Leukocyte Subsets: An HCDM CDMaps Initiative

Distinct CD8 T Cell Populations with Differential Exhaustion Profiles Associate with Secondary Complications in Common Variable Immunodeficiency

Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety

Immunogenicity and Safety of the Booster bnt162b2 Vaccine in Patients With Axial Spondyloarthritis Treated With Biological Disease-Modifying Drugs

Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity - Results From a Multicenter Nationwide Study

Drobečková navigace

Významné publikace

Immunoprofiling of Monocytes in STAT1 Gain-Of-Function Chronic Mucocutaneous Candidiasis

Standardization of Workflow and Flow Cytometry Panels for Quantitative Expression Profiling of Surface Antigens on Blood Leukocyte Subsets: An HCDM CDMaps Initiative

Distinct CD8 T Cell Populations with Differential Exhaustion Profiles Associate with Secondary Complications in Common Variable Immunodeficiency

Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety

Immunogenicity and Safety of the Booster bnt162b2 Vaccine in Patients With Axial Spondyloarthritis Treated With Biological Disease-Modifying Drugs

Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity - Results From a Multicenter Nationwide Study